These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9506739)
21. Identification of naturally occurring follistatin complexes in human biological fluids. Wang EY; Draper LB; Lee E; Polak A; Sluss P; Weiss J; Woodruff TK Biol Reprod; 1999 Jan; 60(1):8-13. PubMed ID: 9858480 [TBL] [Abstract][Full Text] [Related]
22. Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. Khoury RH; Wang QF; Crowley WF; Hall JE; Schneyer AL; Toth T; Midgley AR; Sluss PM J Clin Endocrinol Metab; 1995 Apr; 80(4):1361-8. PubMed ID: 7714112 [TBL] [Abstract][Full Text] [Related]
23. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. Roberts VJ; Barth S; el-Roeiy A; Yen SS J Clin Endocrinol Metab; 1993 Nov; 77(5):1402-10. PubMed ID: 8077341 [TBL] [Abstract][Full Text] [Related]
24. Follistatin binds to both activin and inhibin through the common subunit. Shimonaka M; Inouye S; Shimasaki S; Ling N Endocrinology; 1991 Jun; 128(6):3313-5. PubMed ID: 2036994 [TBL] [Abstract][Full Text] [Related]
25. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. Evans LW; Muttukrishna S; Groome NP J Endocrinol; 1998 Feb; 156(2):275-82. PubMed ID: 9518873 [TBL] [Abstract][Full Text] [Related]
26. Follistatin and its role as an activin-binding protein. Sugino H; Sugino K; Hashimoto O; Shoji H; Nakamura T J Med Invest; 1997 Aug; 44(1-2):1-14. PubMed ID: 9395712 [TBL] [Abstract][Full Text] [Related]
27. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487 [TBL] [Abstract][Full Text] [Related]
28. Competitive protein binding assay for activin A/EDF using follistatin determination of activin levels in human plasma. Demura R; Suzuki T; Tajima S; Mitsuhashi S; Odagiri E; Eto Y; Sugino H; Demura H Biochem Biophys Res Commun; 1992 Jun; 185(3):1148-54. PubMed ID: 1627137 [TBL] [Abstract][Full Text] [Related]
29. Identification of activins and follistatin proteins in human follicular fluid and placenta. Yokoyama Y; Nakamura T; Nakamura R; Irahara M; Aono T; Sugino H J Clin Endocrinol Metab; 1995 Mar; 80(3):915-21. PubMed ID: 7883850 [TBL] [Abstract][Full Text] [Related]
30. Pituitary follistatin regulates activin-mediated production of follicle-stimulating hormone during the rat estrous cycle. Besecke LM; Guendner MJ; Sluss PA; Polak AG; Woodruff TK; Jameson JL; Bauer-Dantoin AC; Weiss J Endocrinology; 1997 Jul; 138(7):2841-8. PubMed ID: 9202226 [TBL] [Abstract][Full Text] [Related]
31. Development and validation of a radioimmunoassay for follistatin in human serum. Gilfillan CP; Robertson DM Clin Endocrinol (Oxf); 1994 Oct; 41(4):453-61. PubMed ID: 7525122 [TBL] [Abstract][Full Text] [Related]
32. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice. Cipriano SC; Chen L; Kumar TR; Matzuk MM Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231 [TBL] [Abstract][Full Text] [Related]
34. Inhibins, activins, and follistatin in the aging female and male. Hurwitz JM; Santoro N Semin Reprod Med; 2004 Aug; 22(3):209-17. PubMed ID: 15319823 [TBL] [Abstract][Full Text] [Related]
35. Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells. Cataldo NA; Rabinovici J; Fujimoto VY; Jaffe RB J Clin Endocrinol Metab; 1994 Jul; 79(1):272-7. PubMed ID: 7517947 [TBL] [Abstract][Full Text] [Related]
36. Expression patterns of activin, inhibin and follistatin variants in the adult male mouse reproductive tract suggest important roles in the epididymis and vas deferens. Winnall WR; Wu H; Sarraj MA; Rogers PA; de Kretser DM; Girling JE; Hedger MP Reprod Fertil Dev; 2013; 25(3):570-80. PubMed ID: 23164397 [TBL] [Abstract][Full Text] [Related]
37. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin. Delbaere A; Sidis Y; Schneyer AL Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830 [TBL] [Abstract][Full Text] [Related]
38. The heparin binding site of follistatin is involved in its interaction with activin. Sumitomo S; Inouye S; Liu XJ; Ling N; Shimasaki S Biochem Biophys Res Commun; 1995 Mar; 208(1):1-9. PubMed ID: 7887917 [TBL] [Abstract][Full Text] [Related]
39. Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Riley SC; Balfour C; Wathen NC; Chard T; Evans LW; Groome NP; Wallace EM Hum Reprod; 1998 Sep; 13(9):2624-8. PubMed ID: 9806296 [TBL] [Abstract][Full Text] [Related]
40. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Schneyer A; Schoen A; Quigg A; Sidis Y Endocrinology; 2003 May; 144(5):1671-4. PubMed ID: 12697670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]